Bliss GVS Pharma Ltd

Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Pros:
Company has reduced debt.
Cons:
Promoter's stake has decreased

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019
141 169 232 258 225 226 196 167 205 228 220 244
101 126 187 181 161 179 148 130 165 187 177 212
Operating Profit 40 43 45 76 64 47 48 38 41 42 44 32
OPM % 28% 25% 19% 30% 28% 21% 25% 22% 20% 18% 20% 13%
Other Income 8 2 8 -7 4 15 2 -29 14 25 -4 3
Interest 4 4 4 8 6 6 5 5 1 1 1 1
Depreciation 4 6 11 1 5 5 7 5 2 2 2 2
Profit before tax 41 35 38 60 56 52 39 -1 51 63 36 32
Tax % 32% 44% 43% 29% 34% 23% 34% -853% 24% 34% 25% 41%
Net Profit 28 14 13 33 21 34 18 -14 39 43 26 18
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 TTM
219 267 397 345 407 547 798 815 898
160 196 285 273 304 391 596 621 741
Operating Profit 59 71 111 71 103 156 203 193 158
OPM % 27% 27% 28% 21% 25% 29% 25% 24% 18%
Other Income 2 16 14 28 20 24 12 -4 38
Interest 2 4 10 18 16 19 20 23 4
Depreciation 5 4 6 11 11 13 20 21 9
Profit before tax 53 79 109 71 96 148 175 145 182
Tax % 23% 34% 46% 42% 36% 32% 36% 39%
Net Profit 41 53 58 41 60 82 82 59 125
EPS in Rs 3.84 4.97 5.48 3.89 5.66 8.00 7.95 5.70
Dividend Payout % 15% 15% 12% 13% 12% 6% 8% 18%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:15.48%
3 Years:26.01%
TTM:10.26%
Compounded Profit Growth
10 Years:%
5 Years:6.14%
3 Years:8.77%
TTM:113.18%
Return on Equity
10 Years:%
5 Years:17.85%
3 Years:18.11%
Last Year:15.08%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
10 10 10 10 10 10 10 10 10
Reserves 156 200 248 277 327 402 476 526 636
Borrowings 8 45 148 173 160 132 225 118 97
39 54 166 124 166 219 312 212 162
Total Liabilities 213 310 571 583 663 763 1,024 866 905
20 40 168 213 234 225 305 143 146
CWIP 8 7 1 4 0 9 4 0 47
Investments 0 1 0 0 0 0 0 0 0
186 262 402 366 428 528 715 722 712
Total Assets 213 310 571 583 663 763 1,024 866 905

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
36 6 41 38 113 289 18
-22 -124 -11 -29 -50 -249 54
26 110 -8 -42 -40 -10 -76
Net Cash Flow 40 -8 22 -34 23 30 -5

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
ROCE % 39% 36% 20% 24% 32% 31% 29%
Debtor Days 200 176 225 228 222 201 116 134
Inventory Turnover 21.96 17.55 10.60 12.29 15.11 18.15 15.04

Recent Announcements

View all announcements

Annual Reports

Credit Ratings